Raw material considerations

Area of Science:

• Biopharmaceutical Manufacturing
• Quality Control
• Analytical Chemistry

Background:

• Raw materials (RM) are integral to biopharmaceutical production, potentially remaining as excipients or contacting products during processing.
• Establishing a strong foundation for well-characterized proteins (WCPs) relies heavily on effective RM testing and control strategies.
• Inadequate control over raw materials can compromise the final product's quality attributes and consistency.

Purpose of the Study:

• To emphasize the necessity of a scientific approach for setting acceptance criteria and test methods for bulk raw materials.
• To guide manufacturers in procuring specified RMs that ensure reliable preparation of WCPs meeting quality attributes.
• To highlight the importance of utilizing pharmacopoeial standards for excipients and process RMs.

Main Methods:

• Application of scientific principles to define acceptance criteria for bulk raw materials.
• Development and implementation of validated test methods for raw material characterization.
• Adherence to existing pharmacopoeial standards for excipients and non-removable process raw materials.

Main Results:

• Procurement of specified raw materials enables the reliable preparation of biopharmaceutical products.
• Consistent adherence to quality attributes is achievable through stringent raw material control.
• Utilization of pharmacopoeial standards ensures a baseline level of raw material quality.

Conclusions:

• A scientific, criteria-based approach to raw material testing is fundamental for well-characterized protein biopharmaceuticals.
• Manufacturers must leverage pharmacopoeial standards and support harmonization efforts for excipients.
• Effective raw material control directly impacts the consistency and quality of the final biopharmaceutical product.